Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation
Alex F. Herrera(City of Hope), Philippe Armand(Harvard University), Tanya Siddiqi(City Of Hope National Medical Center), Tanya Paris, Jasmine Zain(City of Hope), Steven T. Rosen(Unknown), Wing C. Chan(Ontario Institute for Cancer Research), Germán Pihán, Jennifer R. Brown(Dana-Farber Cancer Institute), Dennis D. Weisenburger(University of Nebraska Medical Center), David M. Weinstock(Broad Institute), Joo Y. Song(City Of Hope National Medical Center), Caron A. Jacobson(Dana-Farber Cancer Institute), Arnold S. Freedman(Otsuka (Japan)), Stephen J. Forman(City Of Hope National Medical Center), Christine J. Pak, Haesook T. Kim(Dana-Farber Cancer Institute), Lawrence K. Low, Joyce Murata‐Collins, Scott J. Rodig(Brigham and Women's Hospital), Tracey Stiller, Victoria Bedell, Matthew S. Davids(Dana-Farber Cancer Institute), Matthew Mei(City of Hope), Reid W. Merryman(Harvard University), Heather H. Sun, Gabriel K. Griffin(Harvard University), Raju Pillai(City Of Hope National Medical Center), Larry W. Kwak(The University of Texas MD Anderson Cancer Center), Lihua E. Budde(City Of Hope National Medical Center), Eric D. Jacobsen(Dana-Farber Cancer Institute), Ann S. LaCasce(Otsuka (Japan)), Aliyah R. Sohani(Massachusetts General Hospital), Robert Chen(AstraZeneca (United States)), Young Il Kim(The Catholic University of Korea St. Vincent's Hospital), David C. Fisher(Dana-Farber Cancer Institute), Auayporn Nademanee(City Of Hope National Medical Center), Leslie Popplewell(City Of Hope National Medical Center), Amrita Krishnan(City of Hope), Joycelynne Palmer(City of Hope)
Cited by 187
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k